Citation Impact
Citing Papers
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism
2016 Standout
A Novel Urinary Metabolite Signature for Diagnosing Major Depressive Disorder
2013
Identification and Validation of Urinary Metabolite Biomarkers for Major Depressive Disorder
2012
Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC–MS and NMR Spectroscopic Metabonomic Approach
2015
Drug-HPMA-HuIg Conjugates Effective Against Human Solid Cancer
2005
Ganoderma – A therapeutic fungal biofactory
2006 Standout
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine
2010 Standout
The human keratins: biology and pathology
2008 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Telomerase RNA Levels Limit the Telomere Length Equilibrium
2006 StandoutNobel
C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies
2008
A systematic review of the association between circulating concentrations of C reactive protein and cancer
2007
Polymer conjugates as anticancer nanomedicines
2006 Standout
Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker
2004
Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer
2005
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Cytokeratin Markers Come of Age
2007
Clinical utility of cytokeratins as tumor markers
2004
Immunosuppressive Dendritic and Regulatory T Cells are Upregulated in Melanoma Patients
2007
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
Cancer-related inflammation and treatment effectiveness
2014 Standout
Telomerase: A target for cancer therapeutics
2002
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Serum C‐Reactive Protein Concentration as an Indicator of Remission Status in Dogs with Multicentric Lymphoma
2007
Selective dna‐amplification induced by carcinogens (initiators): Evidence for a role of proteases and DNA polymerase alpha
1985 StandoutNobel
Acute phase response in animals: a review.
2009 Standout
Antitumor Activity of Systemically Delivered Ribozymes Targeting Murine Telomerase RNA
2004 StandoutNobel
Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data
2003
Dendritic cell dysfunction in cancer: A mechanism for immunosuppression
2005
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies
2010
Andrographis paniculata downregulates proinflammatory cytokine production and augments cell mediated immune response in metastatic tumor-bearing mice.
2010
Revised methods for the Salmonella mutagenicity test
1983 Standout
Andrographis paniculata(Burm. f.) Wall. ex Nees: A Review of Ethnobotany, Phytochemistry, and Pharmacology
2014 Standout
The Inhibitory Role of B7-H4 in Antitumor Immunity: Association with Cancer Progression and Survival
2011
Caffeine-mediated Release of Alpha-radiation-induced G2 Arrest Increases the Yield of Chromosome Aberrations
1983
Carcinogenicity in rats of the mutagenic compounds 1-nitropyrene and 3-nitrofluoranthene
1982
Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs
2002
Combination Treatment with Erlotinib and Pertuzumab against Human Tumor Xenografts Is Superior to Monotherapy
2005
Works of Marta Šimíčková being referenced
Release of cytokeratin‐18 and ‐19 fragments (TPS and CYFRA 21‐1) into the extracellular space during apoptosis
2002
Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
2008
Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
1999
Induction of chromosome shattering and micronuclei by ultraviolet light and caffeine. I. Temporal relationship and antagonistic effects of the four deoxyribonucleosides
1980
Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
1999
Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response.
2002
Early diagnosis of breast cancer dissemination by tumor markers follow-up and method of prediction.
1994
Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology
2002